Entecavir as treatment for reactivation of hepatitis B in immunosuppressed patients

doi:10.3748/wjg.v16.i43.5447

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 43

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3662)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

410

HTML

2783

Figures (1-1)

234

Tables (1-1)

235

Sum=3662

Nov 21, 2010 (publication date) through Dec 20, 2024

Times Cited of This Article

Times Cited (26)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Nov 21, 2010; 16(43): 5447-5451
Published online Nov 21, 2010. doi: 10.3748/wjg.v16.i43.5447

Open in New Tab Full Size Figure Download Figure

Figure 1 Temporal changes in laboratory values for patients 1-4 at the time of hepatitis B virus reactivation and on entecavir treatment, including: (A) alanine aminotransferase, (B) hepatitis B virus DNA and (C) quantitative hepatitis B surface antigen levels. ALT: Alanine aminotransferase; HBV: Hepatitis B virus; ETV: Entecavir.

Citation: Brost S, Schnitzler P, Stremmel W, Eisenbach C. Entecavir as treatment for reactivation of hepatitis B in immunosuppressed patients. World J Gastroenterol 2010; 16(43): 5447-5451
URL: https://www.wjgnet.com/1007-9327/full/v16/i43/5447.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i43.5447